Literature DB >> 17974977

Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras.

Krishna Murthi Vasudevan1, Ravshan Burikhanov, Anindya Goswami, Vivek M Rangnekar.   

Abstract

Ras is one of the most commonly mutated oncogenes in the array of human cancers. The mechanism by which Ras induces cellular transformation is, however, not fully elucidated. We present here evidence that oncogenic Ras suppresses the expression of the tumor suppressor phosphatase and tensin homologue deleted from chromosome 10 (PTEN), and this action of oncogenic Ras is mediated by the Raf-mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)-ERK pathway via up-regulation of c-Jun. Jun(+/+) cells undergo cellular transformation by oncogenic Ras, and restoration of wild-type PTEN, but not a phosphate-defective mutant of PTEN, induces apoptosis in these cells. Conversely, in Jun(-/-) cells, oncogenic Ras neither suppresses PTEN nor causes transformation, but rather it induces PTEN-dependent apoptosis. An apoptotic response to oncogenic Ras in Jun(-/-) cells can be prevented by suppressing PTEN expression. These findings imply that oncogenic Ras suppresses the apoptotic gene PTEN via the Raf-MEK-ERK-c-Jun pathway to induce antiapoptosis and cellular transformation. Together, our findings identify a novel molecular interface between the oncogenic and tumor suppressor pathways that regulates cellular transformation and survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17974977     DOI: 10.1158/0008-5472.CAN-07-1827

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells.

Authors:  Mahandranauth A Chetram; Valerie Odero-Marah; Cimona V Hinton
Journal:  Mol Cancer Res       Date:  2010-11-12       Impact factor: 5.852

2.  Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas.

Authors:  Saya H Ebbesen; Maurizio Scaltriti; Carl U Bialucha; Natasha Morse; Edward R Kastenhuber; Hannah Y Wen; Lukas E Dow; José Baselga; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

3.  The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms.

Authors:  Ludovica Ciuffreda; Cristina Di Sanza; Ursula Cesta Incani; Adriana Eramo; Marianna Desideri; Francesca Biagioni; Daniela Passeri; Italia Falcone; Giovanni Sette; Paola Bergamo; Andrea Anichini; Kanaga Sabapathy; James A McCubrey; Maria Rosaria Ricciardi; Agostino Tafuri; Giovanni Blandino; Augusto Orlandi; Ruggero De Maria; Francesco Cognetti; Donatella Del Bufalo; Michele Milella
Journal:  J Mol Med (Berl)       Date:  2012-01-04       Impact factor: 4.599

Review 4.  The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.

Authors:  M R Moniri; L-J Dai; G L Warnock
Journal:  Cancer Gene Ther       Date:  2014-01-03       Impact factor: 5.987

Review 5.  PTEN level in tumor suppression: how much is too little?

Authors:  Arkaitz Carracedo; Andrea Alimonti; Pier Paolo Pandolfi
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

6.  PTEN regulates TLR5-induced intestinal inflammation by controlling Mal/TIRAP recruitment.

Authors:  Yoon Jeong Choi; Jane Jung; Hyo Kyun Chung; Eunok Im; Sang Hoon Rhee
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

7.  RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.

Authors:  Thomas Sebastian; Peter F Johnson
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

Review 8.  PTEN modulators: a patent review.

Authors:  Chandra S Boosani; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2013-02-05       Impact factor: 6.674

9.  UVB-induced ERK/AKT-dependent PTEN suppression promotes survival of epidermal keratinocytes.

Authors:  M Ming; W Han; J Maddox; K Soltani; C R Shea; D M Freeman; Y-Y He
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

10.  A transcriptomic computational analysis of mastic oil-treated Lewis lung carcinomas reveals molecular mechanisms targeting tumor cell growth and survival.

Authors:  Panagiotis Moulos; Olga Papadodima; Aristotelis Chatziioannou; Heleni Loutrari; Charis Roussos; Fragiskos N Kolisis
Journal:  BMC Med Genomics       Date:  2009-12-15       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.